SELVAS Healthcare Launches AI-based Body Composition Analyzer 'ACCUNIQ BC380' Worldwide
SELVAS Healthcare (KOSDAQ:208370) has launched a next generation body composition analyzer ACCUNIQ BC380.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171002005108/en/
ACCUNIQ BC380 is a next-generation intelligent body composition analyzer, which reflects the digital healthcare company’s accumulated product development know-how, cutting-edge information technology and the findings of consumer researches conducted in step with market trends and US clinical test results.
The new analyzer has further raised the accuracy of body composition measurement through its high correlation with Dual Energy X-ray Absorptiometry (DEXA) at a US clinical trial center IHT. It also applied innovative software technologies to product design, UI screens and result sheets.
The industry’s first after-sales service ‘ACCUNIQ Remote Support’ connects users to the customer service department of SELVAS Healthcare remotely from anywhere around the world. As a result, ACCUNIQ BC380 can be diagnosed, repaired and upgraded more easily.
The new product also offers personalized diet and exercise prescriptions personalized on the basis of measurement data in conjunction with ACCUNIQ Manager, proprietary software to manage individual user’s body composition data. It can be linked with a series of ACCUNIQ ultrasound height meter and fully automatic blood pressure monitors.
“By launching ACCUNIQ BC380, we plan to set a new industry standard for body composition analyzers in the global market,” SELVAS Healthcare CEO Ken B. Yoo said, “Our goal is to become a leading digital healthcare company by integrating our expertise in body composition analysis, artificial intelligence and IoT technologies.”
ACCUNIQ BC380 will be exhibited at the MEDICA 2017 (Booth No.11F67), in Dusseldorf, Germany from November 13~16.
SELVAS Healthcare, Inc. was listed on KOSDAQ in September 2016 after it was renamed from Jawon Medical Co., a leading medical device manufacturer since 1993. SELVAS Healthcare has been solidifying its position in the global medical device market by releasing innovative products based on the AI technology of its subsidiary SELVAS AI . Its major products include ACCUNIQ BP850 (a.k.a. EX PLUS 1300), world’s first dual-arm blood pressure monitor which can measure the blood pressures difference between both arms, body composition analyzers, braille terminals, video magnifiers and text-to-speech voice readers.
Kate Kim, +82-2-6190-7676
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
AIAS/D.I.C.E.-CANNES16.8.2018 16:03 | pressemeddelelse
2018 D.I.C.E. Cannes Announced Round 3 Speakers
GN-HEARING16.8.2018 15:02 | pressemeddelelse
GN Hearing and Google Announce Partnership to Bring Direct Mobile Streaming from Android Devices to Hearing Aids
CA-GUIDEWIRE-SOFTWARE16.8.2018 14:57 | pressemeddelelse
Zurich Expands Global Use of Guidewire InsurancePlatform with Selection of Guidewire Cyence Risk Analytics
CA-SCIENTIST.COM16.8.2018 14:08 | pressemeddelelse
Scientist.com Named One of America’s Ten Fastest-Growing Private Companies by Inc. Magazine
KALKITECH16.8.2018 13:01 | pressemeddelelse
REN Using Kalkitech Sync Platform at Substations for Automated Disturbance Record Collection and Data Conversion
CA-FASTFORWARD.AI16.8.2018 12:17 | pressemeddelelse
FastForward.ai Launches “Ooredoo Next”, Myanmar’s New Digital Engagement Platform
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum